Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure
P. Boschetto, B. Bottazzi, A. Fucili, A. Potena, L. Ballerin, M. Stendardo, S. Piva, A. Verduri, B. Beghé, A. Mantovani, L. Fabbri, R. Ferrari, C. Ceconi (Ferrara, Milano, Modena, Italy)
Source: Annual Congress 2011 - COPD exacerbation
Session: COPD exacerbation
Session type: Thematic Poster Session
Number: 574
Disease area: Airway diseases
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
P. Boschetto, B. Bottazzi, A. Fucili, A. Potena, L. Ballerin, M. Stendardo, S. Piva, A. Verduri, B. Beghé, A. Mantovani, L. Fabbri, R. Ferrari, C. Ceconi (Ferrara, Milano, Modena, Italy). Interleukin-6, but not pentraxin 3, predicts adverse clinical outcomes on short-term prognosis of patients with incipient heart failure. Eur Respir J 2011; 38: Suppl. 55, 574
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you: